Symbol: |
IER2
|
Description: |
immediate early response 2 [Source:HGNC Symbol;Acc:28871]
|
Location: |
Chr19:13261282-13265716[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:107
Gene |
Compound |
Gen_sig |
Exp_pattern |
IER2 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.031 |
Up |
IER2 |
NSC 727259 |
0.034 |
Down |
IER2 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.037 |
Up |
IER2 |
gamma-glutamyl-alpha-amino-beta-[[2-ethyl(5-fluoro-2'deoxyur idyl) N-methyl-N-(4-chlorobutyl)phosphoramidoyl]sulfonyl] propionyl-(R)-(-)-phenylglycine |
0.009 |
Up |
IER2 |
NSC 734631 |
0.021 |
Down |
IER2 |
NSC 736189 |
0.028 |
Down |
IER2 |
6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline |
0.033 |
Up |
IER2 |
6-[3-[2-[1,2,4]-Triazolyl-1-propyl]-5,6-dihydro-2,3-dimethox y-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinolin e Hydrochloride |
0.023 |
Up |
IER2 |
NSC 741942 |
0.045 |
Down |
IER2 |
Ethylenediaminetetraacetic acid bis-(5-amino salicylic acid methyl ester) |
0.024 |
Up |
IER2 |
2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
0.007 |
Up |
IER2 |
NSC 745624 |
0.03 |
Up |
IER2 |
NSC 747174 |
0.031 |
Down |
IER2 |
NSC 747452 |
0.028 |
Down |
IER2 |
AZG |
0.041 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:7
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:14
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:25
Total:2 Current:1
[First] [Prev]  Next Last 
|